ENSG vs NHC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ENSG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ENSG and NHC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ENSG and NHC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). As of mid-2026 its subsidiaries operated roughly 398 healthcare operations, including about 48 senior living communities, across 17 states, with a real estate portfolio of roughly 183 properties. The business model is to acquire underperforming but strategically located facilities and turn them into profitable local operations, generating revenue mostly from Medicare, Medicaid, and private-insurance reimbursement for short-term rehab and long-term care.

Full ENSG guide

National HealthCare Corporation runs senior health care under one roof: as of August 2026 its affiliates operate 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living communities with 1,413 units, nine independent living communities with 775 units, three behavioral health hospitals, 34 homecare agencies and 33 hospice agencies, spread across nine states and concentrated in the Southeast. The company reports in two segments, inpatient services and homecare and hospice, and adds smaller lines in pharmacy, rehabilitation therapy, captive insurance and management and accounting services sold to third-party post-acute operators. Founded in Murfreesboro, Tennessee and listed since the 1980s, NHC describes itself as the nation's oldest publicly traded senior care company, and it remains unusually small in share count at roughly 15.7 million shares outstanding.

Full NHC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ENSG drivers: Serial-acquisition growth engine; Occupancy and skilled-mix gains.
• NHC drivers: Owning the buildings instead of renting them; Tuck-in acquisitions inside the existing footprint.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. For NHC, roughly 29% of net patient revenue comes from Medicaid, and the 2025 federal reconciliation law tightens state provider-tax financing beginning in fiscal 2028, which could squeeze the state rates that fund those beds.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ENSG if you believe its drivers more; NHC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ENSG and NHC guides.

ENSG. Ensign trades at a premium to typical healthcare-facility peers, reflecting its consistent double-digit growth and strong balance sheet (roughly $540 million cash against about $143 million of debt in early 2026). Q1 2026 revenue grew about 18% year over year to roughly $1.39 billion with adjusted EPS up more than 20%, and management raised full-year guidance. The premium multiple assumes the acquisition-led growth continues.

NHC. Second-quarter GAAP results were flattered by items that do not repeat: an $18.3 million catch-up of management fees recognized when the affiliate acquisition closed, plus mark-to-market gains on the securities portfolio. Adjusted net income of about $27.6 million, up 7.2% year over year, is the cleaner read on operations, and the gap between $2.54 GAAP and $1.74 adjusted diluted EPS shows how much noise the equity portfolio introduces. Trailing multiples also predate the July 1 NHI closing, so they reflect a rent-paying, debt-free company rather than the property-owning, leveraged one that exists today.

Headline figures (approximate, July 2026): ENSG shows revenue (ttm) ~$5.3B, 2026 revenue guidance ~$5.81B to $5.86B, 2026 eps guidance (diluted) ~$7.48 to $7.62, market cap ~$9.9B; NHC shows revenue (ttm) ~$1.56B, q2 2026 revenue ~$408M (+8.8% YoY), q2 2026 diluted eps ~$2.54 GAAP, ~$1.74 adjusted, market cap ~$3.57B (~$228 per share).

ENSG and NHC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ENSG and NHC exposure against your real portfolio. It is not an investment adviser.